» Articles » PMID: 31249170

The Incremental Benefit of EUS for the Identification of Malignancy in Indeterminate Extrahepatic Biliary Strictures: A Systematic Review and Meta-analysis

Overview
Date 2019 Jun 29
PMID 31249170
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

This systematic review aims to assess the literature to determine the impact of EUS for diagnosing malignancy among indeterminate extrahepatic biliary strictures. A systematic review was performed using MEDLINE, EMBASE, Cochrane, and conference proceedings from inception to July 2016. Pooled results were calculated using random-effects model, and heterogeneity was explored using stratified meta-analysis and meta-regression. The main outcome was the incremental benefit of EUS (IB) for the diagnosis of malignancy among patients who have undergone ERCP with brushing cytology for extrahepatic biliary strictures. Of 3131 identified citations, ten met the inclusion criteria and were included in the final analyses (study periods from 1998 to 2014). Pooled IB estimate with the adjustment for publication bias was 14% (95% confidence interval, 7%-20%). Individual studies demonstrate that the IB is greater for distal biliary strictures or when an extrinsic mass is identified on cross-sectional imaging. EUS increases the identification of malignancy for indeterminate biliary strictures following a nondiagnostic ERCP, particularly those that are distal or related to extrinsic compression.

Citing Articles

Diagnostic Approach to Biliary Strictures.

Raza D, Singh S, Crino S, Boskoski I, Spada C, Fuccio L Diagnostics (Basel). 2025; 15(3).

PMID: 39941254 PMC: 11816488. DOI: 10.3390/diagnostics15030325.


An Approach to and Treatment of Indeterminate Biliary Strictures: A Comprehensive Review of the Literature.

Impellizzeri G, Grassini M, Donato G, De Angelis C, Pagano N J Clin Med. 2025; 14(1.

PMID: 39797112 PMC: 11721181. DOI: 10.3390/jcm14010029.


Optimizing endoscopic diagnosis of biliary strictures of undetermined etiology: a practical guide based on the new ASGE guidelines.

Triki L, Fernandez Y Viesca M, Arvanitakis M Hepatobiliary Surg Nutr. 2024; 13(6):1007-1009.

PMID: 39669091 PMC: 11634432. DOI: 10.21037/hbsn-24-449.


Diagnostic Challenges in Follicular Cholangitis Mimicking Hilar Cholangiocarcinoma: A Case Report and Review of the Literature.

Lee J, Jeong S, Lee D, Choi S, Shin W Medicina (Kaunas). 2024; 60(9).

PMID: 39336554 PMC: 11433704. DOI: 10.3390/medicina60091513.


Biliary Strictures and Cholangiocarcinoma - Untangling a Diagnostic Conundrum.

Ney A, Garcia-Sampedro A, Goodchild G, Acedo P, Fusai G, Pereira S Front Oncol. 2021; 11:699401.

PMID: 34660269 PMC: 8515053. DOI: 10.3389/fonc.2021.699401.


References
1.
Paranandi B, Oppong K . Biliary strictures: endoscopic assessment and management. Frontline Gastroenterol. 2017; 8(2):133-137. PMC: 5318650. DOI: 10.1136/flgastro-2016-100773. View

2.
DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

3.
Heimbach J, Sanchez W, Rosen C, Gores G . Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford). 2011; 13(5):356-60. PMC: 3093648. DOI: 10.1111/j.1477-2574.2011.00298.x. View

4.
Ngamruengphong S, Swanson K, Shah N, Wallace M . Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer. Gut. 2015; 64(7):1105-10. DOI: 10.1136/gutjnl-2014-307475. View

5.
Ikezawa K, Uehara H, Sakai A, Fukutake N, Imanaka K, Ohkawa K . Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. J Gastroenterol. 2012; 48(8):966-72. DOI: 10.1007/s00535-012-0693-x. View